Skip to main content

Table 1 Patient characteristics and clinical laboratory data

From: Performance characteristics between TDx®FLx and TBA™-25FR for the therapeutic drug monitoring of methotrexate

Age (years)

32 (8–73)

Gender [male/female]

12/4

Height (cm)

165 (124.4–178)

Body weight (kg)

50.8 (26.6–75.6)

WBC

5.8 (1.3–22.5)

RBC

3.4 (2.8–4.6)

HGB

10.6 (8.3–15.1)

HCT

31.6 (24.1–41.7)

CRP (mg/dL)

0.20 (0.02–1.85)

Alb (g/dL)

3.8 (2.7–4.5)

TP (g/dL)

6.4 (4.7–7.4)

T.Bil (mg/dL)

0.66 (0.19–1.74)

AST (IU/L)

28.2 (14.2–177.7)

ALT (IU/L)

33.8 (12.5–198.4)

ALP

322.0 (189.0–514.0)

γ-GTP

49.4 (11.1–222.8)

BUN (mg/dL)

12.2 (2.9–30.6)

SCr (mg/dL)

0.60 (0.23–2.05)

CCr

99.6 (43.5–219.1)

  1. Data are expressed as median and interquartile range unless otherwise stated